Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Recurrent Urinary Tract Infection Using Vaginal Testosterone Versus Placebo

NCT04807894 is registered in ClinicalTrials.gov with Jefferson Drapkin as lead sponsor.

NCT NCT04807894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04807894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Recurrent Urinary Tract Infection Using Vaginal Testosterone Versus Placebo
Lead sponsor
Jefferson Drapkin
Phase
Phase 4
Overall status
Terminated
Start date
November 1, 2020
Completion date
August 31, 2026
Enrollment
67 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postmenopausal disorder, recurrent urinary tract infection, vaginal atrophy